These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3653028)

  • 1. Characterization and hormonal regulation of estrogen binding proteins in the MTW-9B transplantable rat mammary tumor.
    Scala DA; Ip MM
    Endocrinology; 1987 Oct; 121(4):1288-98. PubMed ID: 3653028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of estrogen-binding proteins in variants of a rat mammary tumor.
    Scala DA; Ip MM
    Cancer Res; 1987 Aug; 47(16):4287-92. PubMed ID: 3607763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased DNA binding of the estrogen receptor in an estrogen-resistant mammary cancer.
    Baskevitch PP; Vignon F; Bousquet C; Rochefort H
    Cancer Res; 1983 May; 43(5):2290-7. PubMed ID: 6403233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
    Klinge CM; Bambara RA; Zain S; Hilf R
    Cancer Res; 1989 Mar; 49(5):1165-70. PubMed ID: 2492902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of estrogen receptor in estrogen-dependent transplantable rat pituitary tumor MtT/F84.
    Yamamoto K; Aihara M; Hayashi S
    Endocrinol Jpn; 1990 Jun; 37(3):451-62. PubMed ID: 2253596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dichotomous effects of tamoxifen on a transplantable rat mammary tumor.
    Ip MM; Milholland RJ; Rosen F; Kim U
    Cancer Res; 1981 Mar; 41(3):984-8. PubMed ID: 7459886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor binding to nuclei from normal and neoplastic rat mammary tissues in vitro.
    Klinge CM; Bambara RA; Zain S; Hilf R
    Cancer Res; 1987 Jun; 47(11):2852-9. PubMed ID: 3105869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of prenatal exposure to diethylstilbestrol on estrogen and progestin binding proteins in uteri and dimethylbenzanthracene- induced mammary tumors of the rat.
    Heidemann PH; Wittliff JL; Calhoon RE; Boylan ES
    J Toxicol Environ Health; 1981 Oct; 8(4):667-86. PubMed ID: 6802985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen control of cytosol progesterone receptor levels in the MT-W9B transplantable mammary tumor in the rat.
    Ip MM; Milholland RJ; Kim U; Rosen F
    J Natl Cancer Inst; 1982 Sep; 69(3):673-81. PubMed ID: 6955558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of o,p'-DDT with the estrogen-binding protein (EBP) of DMBA-induced rat mammary tumors.
    Mason RR; Schulte GJ
    Res Commun Chem Pathol Pharmacol; 1981 Jul; 33(1):119-28. PubMed ID: 6791254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high-affinity estrogen-binding protein in rat placental trophoblast.
    McCormack SA; Glasser SR
    Endocrinology; 1976 Sep; 99(3):701-12. PubMed ID: 182465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin binding in ovariectomy-responsive and ovariectomy-nonresponsive rat mammary carcinoma.
    Powell BL; Diamond EJ; Koprak S; Hollander VP
    Cancer Res; 1977 May; 37(5):1328-32. PubMed ID: 15719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific binding of estrogen and estrogen-receptor complex by microsomes from estrogen-responsive tissues of the rat.
    Watson GH; Muldoon TG
    Endocrinology; 1985 Oct; 117(4):1341-9. PubMed ID: 4029080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic estrogen responsiveness. Possible mechanisms for sexual dimorphism.
    Thompson C; Lucier GW
    Mol Pharmacol; 1983 Jul; 24(1):69-76. PubMed ID: 6865928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective increase in type II estrogen-binding sites in the dysplastic dorsolateral prostates of noble rats.
    Ho SM; Yu M
    Cancer Res; 1993 Feb; 53(3):528-32. PubMed ID: 7678774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-binding proteins in R3230AC mammary tumors of intact and diabetic rats.
    Korc-Grodzicki B; Ren N; Hilf R
    Endocrinology; 1993 Nov; 133(5):2362-70. PubMed ID: 7691588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of intestinal estrogen receptor by ovariectomy, estrogen and growth hormone.
    Chen C; Kalu DN
    J Pharmacol Exp Ther; 1998 Jul; 286(1):328-33. PubMed ID: 9655876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the estrous cycle during carcinogen exposure on nitrosomethylurea-induced rat mammary carcinoma.
    Lindsey WF; Das Gupta TK; Beattie CW
    Cancer Res; 1981 Oct; 41(10):3857-62. PubMed ID: 7197191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target cells for the polychlorinated biphenyl metabolite 4,4'-bis(methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl. Characterization of high affinity binding in rat and mouse lung cytosol.
    Lund J; Brandt I; Poellinger L; Bergman A; Klasson-Wehler E; Gustafsson JA
    Mol Pharmacol; 1985 Feb; 27(2):314-23. PubMed ID: 3918256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of two forms of molybdate-stabilized estrogen receptor.
    Ruh MF; Ruh TS
    Endocrinology; 1984 Oct; 115(4):1341-9. PubMed ID: 6479095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.